"Graft vs Leukemia Effect" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunological rejection of leukemia cells following bone marrow transplantation.
| Descriptor ID |
D020544
|
| MeSH Number(s) |
G12.875.402.320.320
|
| Concept/Terms |
Graft vs Leukemia Effect- Graft vs Leukemia Effect
- Graft-vs-Leukemia Response
- Graft-vs-Leukemia Responses
- Response, Graft-vs-Leukemia
- Responses, Graft-vs-Leukemia
- Graft vs Leukemia Response
- Graft-vs-Leukemia Effect
- Effect, Graft-vs-Leukemia
- Effects, Graft-vs-Leukemia
- Graft-vs-Leukemia Effects
|
Below are MeSH descriptors whose meaning is more general than "Graft vs Leukemia Effect".
Below are MeSH descriptors whose meaning is more specific than "Graft vs Leukemia Effect".
This graph shows the total number of publications written about "Graft vs Leukemia Effect" by people in this website by year, and whether "Graft vs Leukemia Effect" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 2 | 3 |
| 2001 | 0 | 3 | 3 |
| 2002 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 5 | 2 | 7 |
| 2008 | 1 | 1 | 2 |
| 2009 | 2 | 3 | 5 |
| 2010 | 1 | 1 | 2 |
| 2011 | 2 | 1 | 3 |
| 2012 | 3 | 1 | 4 |
| 2013 | 2 | 0 | 2 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 1 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Graft vs Leukemia Effect" by people in Profiles.
-
Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trial. J Hematol Oncol. 2024 06 27; 17(1):50.
-
Reduced dose of PTCy followed by adjuvant a-galactosylceramide enhances GVL effect without sacrificing GVHD suppression. Sci Rep. 2021 06 23; 11(1):13125.
-
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant. Blood. 2021 05 13; 137(19):2585-2597.
-
NK cell alloreactivity in acute myeloid leukemia in the post-transplant cyclophosphamide era. Am J Hematol. 2020 12; 95(12):1590-1598.
-
Inhibition of inositol kinase B controls acute and chronic graft-versus-host disease. Blood. 2020 01 02; 135(1):28-40.
-
The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia. Blood Adv. 2019 02 26; 3(4):670-680.
-
Computational modeling and confirmation of leukemia-associated minor histocompatibility antigens. Blood Adv. 2018 08 28; 2(16):2052-2062.
-
Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial. Biol Blood Marrow Transplant. 2016 07; 22(7):1290-1298.
-
Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation. Haematologica. 2016 05; 101(5):e204-8.
-
T-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effect. Haematologica. 2015 Jun; 100(6):709-19.